GLP-1 agonists are an effective medication in treating type 2 diabetes mellitus. GLP-1 agonists are a synthetic version of the body’s naturally occurring GLP-1. However, synthetic GLP-1 has the advantage of being resistant to DPP4 degradation. GLP-1 agonists have...
Glucagon-like peptide-1 receptor agonists, or GLP-1s, are a highly appealing, newer class of medications for the treatment of type 2 diabetes. Through their activity at the GLP-1 receptor, they slow gastric emptying and decrease glucagon secretion. They also increase...
I’ve encountered numerous patients who are taking chronic, oral corticosteroids. We know that there are numerous potential adverse effects from long term corticosteroid use. Osteoporosis, cardiovascular risks, diabetes, and cataracts are a few of the potential...
Sodium-glucose co-transporter 2 inhibitors (SGLT2s) are becoming popular treatments for type 2 diabetes mellitus. While typically classified as diabetes medications, there is more and more research coming out for their benefits in cardiovascular health and heart...
Many patients are labeled as having a “sulfa allergy”. This is typically going to be from a reaction to sulfa antibiotics (i.e. sulfamethoxazole). Sulfonylureas are one of the drug classes that have sulfonamides as part of their chemical structure so therefore a...
Sean Navin is a clinical pharmacist who graduated in 2015 from my alma mater (University of Minnesota – Duluth). I’m excited to have him share his breakdown on Medications Targeting Pre- and Post-Prandial Glucose! You can track him down here. When managing...
